Home » Topics » BioWorld

BioWorld
RSS

AMYLIN RECEIVES FIRST PATENT NOTICE

Jan. 28, 1992

BLOOD VIRUS ELIMINATION PROJECT ABORTED

Jan. 27, 1992

BIOSYS FILES FOR 2.3 MILLION-SHARE IPO

Jan. 27, 1992

HYBRIDON PATENT FOR ANTISENSE COMPOUND

Jan. 27, 1992

SBIR FOR PROTEASE ENZYME INHIBITORS

Jan. 27, 1992

APPOINTMENTS AND ADVANCEMENTS

Jan. 27, 1992

VERTEX SBIR FOR CRYSTALIZED ENZYMES

Jan. 27, 1992

ENZON TO CO-DEVELOP CANCER TREATMENT

Jan. 27, 1992

PROTEIN POLYMER RAISES $9.4M IN IPO

Jan. 27, 1992

FEVERISH IPO WEEK CLOSES ON TARGET

Jan. 27, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...